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Abstract 
We studied the effect of 12-36 min of global ischemia followed by 36 min of reperfusion i Langendorffperfused rabbit hearts 
(n = 26). Metabolism was determined in terms of peak and total release ofpurines (adenosine, inosine, hypoxanthine), lactate 
and noradrenaline during reperfusion; and myocardial content of nucleotides (ATP, ADP, AMP), glycogen and noradrenaline 
at the end of reperfusion. An inverse relationship (r = -0.79) existed between duration of ischemia nd developed pressure 
post-ischemia. Early during reperfusion, after 12 min of ischemia, the purine concentration (peak release) increased 100x (p 
< 0.01), that of lactate and noradrenaline 10x (p < 0.05). Total purine release rose with progression of the ischemic period 
(30x after 36 min ofischemia; p < 0.01), concomitant with a reduction in nucleotide content. Lactate release was independent 
from the duration of ischemia, although glycogen had declined by 30% (p < 0.01) after 36 rain ofischemia. The acid insoluble 
glycogen fraction, which presumably contains proglycogen, increased substantially during short-term ischemia. Peak noradrena- 
line increased 100x and 200x (p < 0.05) after 24 and 36 min ofischemia, respectively. Total noradrenaline r lease due to vari- 
ous periods of ischemia mirrored its peak release. Function recovery was inversely related to total purine and noradrenaline 
effiux (both r = -0.81); it correlated with tissue nucleotide content (r = 0.84). In conclusion, larger amounts of noradrenaline 
are released only after a substantial drop in myocardial ATR During severe ischemia ATP consumption more than limited ATP 
production by anaerobic glycolysis, is a key factor affecting recovery on subsequent reperfusion. In contrast to lactate fflux, 
purine and noradrenaline r lease are useful markers of ischemic and reperfusion damage. (Mol Cell Biochem 160/161:187- 
194, 1996) 
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Introduction 
Many critical factors are involved in the onset of severe 
myocardial ischemic damage. The most important are: (1) 
loss of tissue adenine nucleotide with consequent failure to 
restore nergy metabolism with reperfusion [ l~i]; (2) accu- 
mulation of toxic metabolites [7-9]; (3) calcium overload 
[ 10]; (4) release of noradrenaline [ 11-15]. Data about hese 
metabolic alterations, however, derive from a combination 
of several individual studies employing a variety of differ- 
ent experimental preparations and ischemic protocols. In ad- 
dition, the analytical techniques utilized for enzymatic 
determination f catecholamine and of adenine nucleotide of- 
ten are of low sensitivity [4, 8, 12, 16, 17]. 
There is therefore the need of systematic data analyzing in 
details the temporal sequences of the metabolic alterations 
which occur as ischemia progresses inthe light of finding out 
the more suitable index ofischemic and reperfusion damage. 
Isolated perfused heart preparation was selected for the 
present study because itallows the control of many variables 
that in vivo influence the severity of ischemic damage such 
as: myocardial perfusion, work load, substrate availability, 
neurohumoral factors. 
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Materials and methods 
Heart per fusion 
Male New Zealand white rabbits (2.0-2.3 kg), maintained on 
a standard iet, were used. They were treated in conformity 
with the guiding principles of the American Physiological So- 
ciety. The animals were stunned by a blow on the head; the 
hearts were quickly removed and perfused as previously 
described [ 18]. The per fusion solution was heated to 37°C, 
bubbled with 95% 02 and 5% CO 2 and transported ata rate 
of 22 ml/min to the aortic cannula with a Gilson Minipuls 2 
rotary pump. The hearts were jacketed (40~4°C) to provide 
a constant myocardial temperature of 37°C, independent of
coronary flow, checked by an Ellab thermometric probe 
(model CTD 85) in the pulmonary artery. They were paced 
using suprathreshold rectangular pulses at 0.1 ms duration 
at a rate of 180 beats/rain. 
After a 30-min period of aerobic equilibration (22 ml/min), 
the hearts were randomly divided into four groups: Control, 
these hearts (n = 7) were aerobically perfused for a further 
period of 60 rain (no ischemia); the other hearts were made 
ischemic by stopping the coronary flow for: (A) 12 min (n = 
7); (B) 24 rain (n = 6); (C) 36 rain (n = 6). At the end of 
ischemia, coronary flow was reestablished and all ischemic 
hearts were reperfused for 36 rain. Left ventricular pressure 
was determined from a fluid-filled balloon inserted into the 
ventricular cavity as previously described [ 18]. 
fraction was neutralized with KOH, and analyzed for nucle- 
otide and catecholamine content. Nucleotides were deter- 
mined by HPLC using the method of Harmsen et al. [23]. 
After A1203 extraction, noradrenaline was assayed as de- 
scribed above. Another aliquot was neutralized with NaOH, 
and analyzed enzymatically for glycogen content [24, 25], 
using rabbit-liver glycogen as tile standard. 
In the acid precipitate, protein and glycogen were assayed. 
Protein was measured according to Bradford [26] using bo- 
vine serum albumine as the standard. A factor of 70 mg pro- 
tein/g wet weight was used to express release data, based on 
heart weight, per gram protein. Glycogen was determined as
described before [24, 25]. 
Statistics 
Data are reported as mean + S.E.M. A one-way analysis of 
variance was first carried out to test for any differences be- 
tween all groups. Ifa difference was established, each of the 
groups was compared with the control group (aerobic on- 
trol), using the unpaired t-test with Bonferroni correction. 
p < 0.05 was considered significant. 
Results 
Mechanical changes 
Biochemical assays 
Analysis of coronary effluent 
Coronary effluent fractions were collected in cooled vials 
(0°C) at regular intervals during the entire period of reper- 
fusion for purine, catecholamine and lactate determinations. 
Two ml ofperfusate were added to 30 tal 10 mM Na2S20 ~ for 
catecholamine assay. Another aliquot (0.5 ml) was added to 
1.0 ml HC104 (6%) for the assay of lactate. Treated and un- 
treated samples were stored at-80°C. Purines were deter- 
mined with our reverse-phase high-pressure liquid chromato- 
graphy (HPLC) method with detection at 254 nln [19, 20]. 
Noradrenaline was determined by reverse-phase HPLC with 
electrochemical detection on perfusate xtracted with A1203 
as previously described by us [21]. L-lactate was enzyma- 
tically determined by the method of Noll [22]. 
During 60 min of control aerobic perfusion, mechanical func- 
tion was well maintained since developed pressure declined 
only by 15% (n.s.). The recovered pressures, measured at the 
end of reperfusion after different ischemic periods are depicted 
in Fig. 1. Compared with the control group, there was a com- 
plete recovery of developed pressure in group A, while, with 
prolongation ofischemia, it significantly decreased ingroups 
B and C (to 66% and 38% of control, respectively; p < 0.01, 
see Fig. 1). There was an inverse relationship (y= 61.69-1.04x; 
r =-0.79, p < 0.001) between the duration ofischemic period 
and the recovered pressure during reperfusion. 
Diastolic pressure in the control hearts remained 0 mmHg 
during the whole time of perfusion. The same was true for 
the hearts in group A. However, in groups B and C it rose to 
24 + 11 and44 + 14 lmnHg, respectively (p< 0.001 vs con- 
trol, at the end of reperfusion) (Fig. 1). 
Tissue determinations 
At the end of the experiments, the hearts were clamped with 
precooled Wollenberger tongs and stored in liquid nitrogen. 
The frozen tissue was homogenized with HC104. The mix- 
ture was thawed and centrifuged; an aliquot of the supernatant 
Metabolite release 
When the hearts were perfused under aerobic conditions, 
small amounts of purine (adenosine, inosine and hypoxan- 
thine), noradrenaline and lactate were present in coronary 
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Fig. 1. Recovery of developed pressure and development ofdiastolic pres- 
sure after various periods of ischemia: decline in mechanical recovery and 
increment in diastolic tension are only evident after prolonged ischemia. 
For the non-ischemic controls (aerobic perfusion), the 60 rain perfusion 
values were used. Mean values + S.E.M. (n = 6-7) are depicted. Pre-inter- 
vention left ventricular systolic pressure was 63.1 ± 2.5 mmHg and diastolic 
pressure was 0 mmHg (n = 26). 
effluent. Peak release of these metabolites was observed ur- 
ing the first minute of reperfusion (groups A, B and C, Fig. 
2). Purine release, which was very low in control hearts 
(0.044 -+ 0.004 gmol/m!n/g protein), became 100-fold higher 
after 12 rain ofischemia (group A; p < 0.01). If the ischemic 
period was prolonged from 12 to 24 rain (group B) it in- 
creased and it doubled after 36 rain ofischemia (group C, Fig. 
2A). The peak releases of individual purines are shown in 
Table 1. Inosine represented the major component of total 
purine released in the aerobic period (42%). After various 
ischemic periods (groups A, B and C), release of all purines 
increased. In particular, during reperfusion, inosine rose to 
63% in group C, at the expense of adenosine. 
Peak noradrenaline r lease (Fig. 2B) rose 10 fold in group 
A (p < 0.05 vs Control) and by an extra two orders of mag- 
nitude in groups B and C. Peak lactate release reached already 
a plateau in group A (p < 0.01 vs Control, see Fig. 2C). 
Noradrenaline and lactate release declined to baseline in 
a few minutes (4 rain for group B) whereas purine release 
persisted substantially longer (7-8 rain for group B; Fig. 3). 
Figure 4 shows the total release of the compounds deter- 
mined in perfusate collected uring 36 rain of reperfusion. 
The behaviour observed for purines was quite similar to that 
described for their peak release (compare Figs. 2A and 4A). 
Total noradrenaline release in group A was not different from 
that in control (Fig. 4B), whereas peak release in group A 
exceeded that in control 10-fold (Fig. 2B). No increment in 
total actate release was observed after ischemia in groups A, 
B and C; all values were comparable to those obtained for 
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Fig. 2. Differences in peak release pattern of purines, noradrenaline and 
lactate after various periods of ischemia. Purines comprise adenosine, ino- 
sine and hypoxanthine. Please, note that the catecholamine data are given 
on a logarithmic scale. For other details, see legend to Fig. 1. 
aerobic ontrol perfusion (Fig. 4C), contrasting the behav- 
iour of peak lactate release (Fig. 2C). 
Tissue changes 
The myocardial content of nucleotides ( um of ATP, ADP, 
and AMP), noradrenaline and glycogen is shown in Fig. 5. 
In groups A, B and C, total nucleotide content decreased (p
< 0.01) compared with aerobic control (to 76%, 43% and 
21%, respectively, see Fig. 5A). The ATP, ADP and AMP 
levels are specified in Table 1. There was a significant de- 
cline in ATP and ADP levels, proportional with the duration 
of the ischemic period. In contrast, AMP content decreased 
in group A (p < 0.05), and increased in groups B (p < 0.01) 
and C (n.s.). 
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Table 1. Purine release as well as nucleotide content after various periods ofischemia 
Variable Aerobic control lschemic period (rain) 
12 24 36 
(Group A) (Group B) (Group C) 
Peak release (gmol/min/g 
protein) 
Adenosine 
Inosine 
Hypoxanthine 
Total release (gmol/36'/g protein) 
Adenosine 
Inosine 
Hypoxanthine 
Tissue content (gmol/g protein) 
ATP 
ADP 
AMP 
Energy charge 
0.015 + 0.002 0.89 + 0.12 0.92 + 0.28 1.30 + 0.70 
0.020 + 0.002 3.09 + 0.26** 4.82 + 0.53** 5.84 +- 0.84** 
0.009 + 0.001 0.84 + 0.06** 1.87 + 0.15"* 2.14 + 0.11 ** 
0.49 + 0.07 1.29 + 0.15" 3.14 + 0.71"* 3.26 + 0.63** 
0.76 + 0.09 6.19 + 0.34** 15.11 + 1.76"* 19.08 + 2.55* 
0.37 + 0.03 1.55 + 0.08** 4.75 + 0.41"* 5.87 + 0.52** 
35.2 + 1.5 27.2 + 1.3 13.3 -+ 2.2** 5.12 + 1.04"* 
5.94 + 0.31 4.35 :k 0.12"* 3.07 + 0.13"* 2.22 + 0.21 ** 
1.01 + 0.11 0.52 :t: 0.06* 1.81 + 0.12"* 1.16 -+ 0.23 
0.905 + 0.005 0.915 + 0.004 0.804 + 0.021"* 0.675 ~: 0.044** 
The values pertain to the 36-min reperfusion period, either early (peak release), over the whole period (total release), or to the end (myocardial content). The 
data show major ATP breakdown after the longer periods of ischemia. Energy charge is [(ATP) + 0.5 (ADP)]/[(ATP)+(ADP)+(AMP)]. Mean + S.E.M.; n = 
5-7. *p < 0,05, **p < 0.01 vs control values 
Besides myocardial  nucleotide content, the phosphocrea- 
tine (PCr) tissue level was determined. In the control group, 
it amounted to 56.3 + 3.4 gmol/g protein at the end of ex- 
periment. No significant differences were observed ue to 
ischemia/reperfusion. 
Energy-charge data are useful to complete the view on 
myocardial  energetic status in the reperfused hearts after 
various ischemic periods. The aerobic control value was 
0.905 + 0.005. Only in groups B and C energy charge de- 
creased, to 88% and 75% with respect o control (p < 0.01, 
Table 1). 
Panels B and C of Fig. 5 depict he noradrenaline and gly- 
cogen content. They show a decrease with the prolongation of 
the ischemic period from 12 min to 24 and 36 rain. The decre- 
ments in noradrenaline content were not statistically signifi- 
cant. Total glycogen decreased to 49% and 30% in groups B 
and C, respectively (p < 0.001 vs Control, F ig.  5C). Acid-in- 
soluble glycogen increased from 7.3 + 0.4 mg/g protein in the 
control group to 17.1 ± 1.6 (group A, p < 0.001), 12.3 + 1.9 
(group B, p < 0.05) and 7.7 ± 1.3 mg/g protein (group C, n.s,) 
Correlation between function and metabolism 
The linear correlations between the recovery of  developed 
pressure upon reperfusion and metabolite release (peak and 
total) as well as tissue content are reported in Table 2. A lin- 
ear inverse and significant relationship existed between re- 
covery of function and peak release ofpurines, noradrenaline 
and lactate, although in the last case, the correlation coeffi- 
cient is low. The myocardial nucleotide and glycogen con- 
tents correlated strongly with developed pressure. Total 
lactate release and noradrenaline tissue content exhibited no 
linear relation with recovered mechanical function. 
Discussion 
Energy metabolism 
We observed, in line with literature [6, 27-29], that reper- 
fusion was unable to restore basal levels of cardiac adenine 
nucleotide content (Fig. 5A). This is especially true for ATP 
stores (see Table 1). In contrast to ATP, phosphocreatine was 
resynthetized during reperfusion. The finding of  a declined 
AMP content in the hearts reperfused after 12 min ofischemia 
could be explained with the increased AMP dephosphoryla- 
tion which occurs in anoxic and ischemic onditions. On the 
other hand, more severe ischemia causes large ATP catabo- 
lism with a probable congestion of the breakdown pattern and 
consequent AMP accumulation. More specifically, this ac- 
cumulation could be due to increased cytosolic Pi which in- 
hibits the activity of 5'-nucleotidase, the enzyme responsible 
for cardiac adenosine production [30]. 
Our data reveal that the lacking recovery in tissue adenine 
nucleotides, compared with aerobic levels, was balanced with 
purines lost during the reperfusion period (Table 1). This 
indicates that a portion of  ATP, consumed uring ischemia, 
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Fig. 3. Time course of metabolite release after 24 rain of ischemia. The 
efflux of noradrenaline and lactate is already back to baseline in 4 rain, 
when purine release is still elevated. For other details, see legend to Fig. 1. 
was not only degradated toADP and AMP, but catabolized 
to adenosine, inosine and hypoxanthine which were imme- 
diately released from myocytes. Further degradation ofhy- 
poxanthine does not take place in rabbit heart [31]. 
After exhaustive ATP depletion during total ischemia [32], 
ATP levels can be partly restored uring reperfusion from ADP 
by oxidative phosphorylation. But ATP resynthesis by the 
purine salvage pathway is too slow to play an important role 
in a relatively brief reperfusion period [6, 28, 29]. These data 
suggest that ATP degradation to purines during ischemia could 
slow high-energy phosphate restoration during reperfusion 
with delayed mechanical and metabolic ardiac recovery 
(stunned myocardium; ref. [27]). Our findings also emphasize 
the specificity ofpurine release to characterize the occurrence 
of myocardial ischemic onditions [33], where lactate release 
seems to be inadequate as a marker (Figs. 2 and 4). 
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Noradrenaline release and tissue content 
The study ofnoradrenaline release rate is of relevance in oxy- 
gen deprivation conditions as already evidenced by the 
pionieristic work ofWollenberger A. et al. [34]. We found a 
large noradrenaline r lease at the first minute of reperfusion 
(peak release) after 12, 24 or 36 min of ischemia (Figs. 2B 
and 3B). This noradrenaline effiux represents washout of the 
neurotransmitter accumulated within the extracellular space 
during the ischemic period [14, 35, 36]. We observed also an 
increment of noradrenaline release during the whole 
reperfusion period (total release), after 24 and 36 rain of 
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ischemia (Fig. 4B), and a balanced, progressive, but not sig- 
nificant, decline in myocardial noradrenaline content (Fig. 
5B). On the other hand, it should be recalled that noradrena- 
line released uring reperfusion represents only a small por- 
tion, from 0.1-14%, of the basal tissue content• 
Based on the positive relationship between total noradrena- 
line release and total purine release (r = 0.80, p < 0.001) and 
on the inverse correlation with ATP myocardial levels 
(r =-0.75, p < 0.001) and glycogen content (r = -0.71, p < 
0.001), we propose the following influence of endogenous 
noradrenaline onenergetic and carbohydrate metabolism dur- 
ing myocardial ischemia. Released noradrenaline stimulates 
glycogenolysis by cyclic-AMP formation and activation of 
phosphorylases, asearlier suggested [13, 37]. Metz and 
Bemauer [16] hypothesized that noradrenaline r lease is not 
essential for the activation of anaerobic glycogenolysis, but 
is important for stimulating anaerobic glyeolysis [ 14]. How- 
ever, these authors found no evidence for an alternative r gu- 
lating mechanism during ischemia [16]. 
Our data also suggest that cardiac noradrenaline, .g. by 
activation of a phosphatase uch as mitochondrial ATPase, 
could affect breakdown of ATP stores, exacerbating the 
ischemic onsumption ofhigh-energy phosphates• However, 
little is known about he effect of noradrenaline on metabo- 
lism during myocardial ischemia, in contrast to the great 
number of studies on its arrhythmogenic and inotropic effects 
upon reperfusion [ 11, 13-15). In the light of these novel data 
and observation, the metabolic role ofnoradrenaline released 
during ischemia deserves more attention• As a marker of 
ischemia, it is perhaps only useful after longer periods of 
ischemia (cf. Figs. 2B and 4B). 
OP<0.01 tOP<0.001 vs Control 
Fig. 5. Decline in tissue nucleotide, noradrenaline, and glycogen content 
after various periods of ischemia. Adenine nucleotides comprise ATP, ADP 
and AMR Glycogen found in the acid-soluble (sup) and acid-insoluble 
(ppt) fractions is given in the upper and lower portions of the bars, respec- 
tively. The ratio sup/ppt in the post-ischemic groups differed from Control 
(p < 0.001). The data show substantial nucleotide and glycogen (acid-solu- 
ble) breakdown with increased uration of ischemia, with minor changes 
in noradrenaline content. The shorter period of ischemia induces an in- 
crease in the acid-insoluble glycogen fraction, which presumably comprises 
proglycogen. For other details, see legend to Fig. 1. 
Glycolytic metabolism 
The glycolytic pathway is profoundly changed by ischemia. 
In the early phase of ischemia, glycogenolysis is stimulated 
by local catecholamine release [ 13]; phosphofructokinase is 
activated by an increase in ADP, AMP and Pi levels and a 
contemporary eduction in ATP content [37]. As a result, 
anaerobic glycolysis i  accelerated, with ATP production and 
lactate accumulation [5]. We have studied alterations ingly- 
Table 2. Correlation between function recovery and metabolic variables after various periods ofischemia 
Peak Concentration (per g protein) Release (per 36'/g protein) Tissue Content (per g protein) 
Purine NorA Lactate Purine Nora Lactate Nucl NorA Glycogen 
(pmol/) (nmol/) (mmol/) (~tmol/) (nmol/) (mmol/) (~mol/) (nmol/) (mg/) 
vs Developed pressure r M3.66 ~).81 ~).41 -0.81 -0.81 -0.32 0.84 0.21 0.84 
p < 0.001 < 0.001 < 0.05 < 0.001 < 0.001 n.s. < 0.001 n.s. < 0.001 
Calculated are the correlation coefficients and their p-values for developed pressure vs peak and total release of metabolites, and vs tissue compounds. 
Function data, obtained at the end ofnormoxic ontrol perfusion and after 36 min ofreperfusion were used. Mean + S.E.M. (n = 24-26). NorA = noradrenaline, 
Nucl = adenine nucleotides 
colytic metabolism, determining myocardial glycogen con- 
tent and lactate release upon reperfusion. In agreement with 
the literature [ l 7], our results how that, after eperfusion, the 
glycogen content was reduced proportionally with the dura- 
tion of ischemia. Furthermore, myocardial glycogen levels 
were closely correlated with the recovery of developed pres- 
sure after different ischemic periods (Table 2). We expected 
lactate release during reperfusion to be correlated with gly- 
cogen consumption. During 36 min of reperfusion, we ob- 
served that all reperfused hearts maintained a total lactate 
release similar to control hearts (Fig. 4C). However, at the 
first minute of reperfusion, all treated groups howed ahigh 
lactate release, compared with aerobic release. These peak 
releases were independent ofthe period of ischemia (12-36 
rain, Fig. 2C). Increased peak release is in apparent contrast 
with correspondent unchanged total release (cf. Fig. 2C and 
4C), but is explained by lower-than-baseline lactate release 
after the early minutes of reperfusion (Fig. 3C). 
We want to underline that lactate washout is independent 
from the duration of ischemia. Possible mechanisms include 
either a saturable lactate xport from the myocardial cells or 
an inhibition of anaerobic glycolysis, without astop in glycog- 
enolysis. The first hypothesis  unproved because lactate ac- 
cumulating intissue was released approximately in propolntion 
to the tissue concentration [38]. The latter hypothesis  sup- 
ported by several studies: when ischemia is prolonged, glyc- 
eraldehyde-3-phosphate dehydrogenase and phosphofructo- 
kinase are inhibited by excess NADH, acidosis and lactate 
accumulation [39-42]. Therefore, lactate production stops 
while other glycolytic products accumulate in myocytes, uch 
as glucose-1-phosphate nd glucose-6-phosphate [5, 41, 43, 
44]. For this reason lactate as a quantitative marker for myo- 
cardial ischemia is unacceptable (see also Figs. 2C and 4C). 
Apstein et al. [45] already pointed at the limitations of lactate 
production as an index of myocardial ischemia. 
A novel observation is the substantial increase in acid-in- 
soluble glycogen due to 12 or 24 rain of ischemia, followed 
by reperfusion. This fraction presumably comprises of 
proglycogen, a low-molecular-weight form of glycogen with 
the protein glycogenin attached to it [46]. Glycogenin primes 
glycogen biogenesis [47]. Further investigations have to sub- 
stantiate that proglycogenin, described for skeletal muscle 
[46], does indeed occur in myocardial tissue, where it may 
be affected by ischemia/reperfusion. 
Conclusion 
Our data demonstrate hat: (1) impaired restoration of myo- 
cardial function during reperfusion is correlated with a large 
loss ofpurines and consequent delay to reestablish adequate 
myocardial energy metabolism; (2) ATP production by 
anaerobic glycolysis is independent from the duration of 
193 
ischemia; (3) cardiac noradrenaline r lease is possibly in- 
volved in aggravating energy waste during ischemia. These 
findings suggest that manipulations which increase nergy 
saving during ischemia [5] or that inhibit purine release, with 
accelerated repletion of ATP stores on reperfusion [ 19, 29], 
are useful to improve mechanical function during post- 
ischemic reperfusion. Incontrast to lactate release, purine and 
possibly noradrenaline release are useful markers efischemic 
damage. 
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